BioCentury | Jul 13, 2015
Clinical News

Delenex preclinical data

...In a mouse xenograft model of glioma, DLX1008 significantly improved survival and inhibited tumor growth vs...
...monovalent antibody fragment against VEGF-A to treat glioblastoma. Delenex Therapeutics AG , Zurich, Switzerland Product: DLX1008...
BioCentury | Jul 13, 2015
Clinical News

Delenex preclinical data

...In a mouse model of Kaposi’s sarcoma, intraperitoneal 15 mg/kg DLX1008 given 5 days per week...
...monovalent antibody fragment against VEGF-A to treat glioblastoma. Delenex Therapeutics AG , Zurich, Switzerland Product: DLX1008...
Items per page:
1 - 2 of 2